Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-09-30

FDA Approved: OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for a generic fixed-dose combination of olmesartan medoxomil and hydrochlorothiazide for the treatment of hypertension. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Olmesartan Medoxomil and Hydrochlorothiazide (olmesartan medoxomil; hydrochlorothiazide)

Snippet

SUPPL AP for OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE (OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE)